Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

40.00 -0.68 (-1.67%)
Streaming Delayed Price Updated: 1:14 PM EDT, Sep 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about PROCEPT BioRobotics Corporation - Common Stock

< Previous 1 2 3 Next >
Assessing PROCEPT BioRobotics: Insights From 4 Financial Analysts
 
Via Benzinga
Procept (PRCT) Q2 Revenue Jumps 48%
Via The Motley Fool
Topics Artificial Intelligence
PROCEPT BioRobotics (PRCT) Earnings Transcript
Via The Motley Fool
Topics World Trade
PROCEPT BioRobotics Corp. (NASDAQ:PRCT) Reports Q2 2025 Revenue Growth but Misses Profitability Targets, Triggering After-Hours Decline
PROCEPT BioRobotics posted strong Q2 2025 revenue growth of 48% YoY but missed profitability estimates, triggering an 8% stock drop. The surgical robotics firm raised full-year guidance but faces... 
Via Chartmill
Earnings Scheduled For August 6, 2025
 
Via Benzinga
Uncovering Potential: PROCEPT BioRobotics's Earnings Preview
 
Via Benzinga
Where PROCEPT BioRobotics Stands With Analysts
 
Via Benzinga
Earnings Scheduled For April 24, 2025
 
Via Benzinga
4 Analysts Assess PROCEPT BioRobotics: What You Need To Know
 
Via Benzinga
Earnings Scheduled For February 25, 2025
 
Via Benzinga
How Is The Market Feeling About PROCEPT BioRobotics?
 
Via Benzinga
Spruce Point Sees Trouble Ahead For Procept BioRobotics
Spruce Point Capital warns of Procept BioRobotics' overstated market potential and growth claims, citing niche product limitations and valuation risks. 
Via Benzinga
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges. 
Via Benzinga
5 Analysts Assess PROCEPT BioRobotics: What You Need To Know
 
Via Benzinga
This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
 
Via Benzinga
Looking Into PROCEPT BioRobotics's Recent Short Interest
 
Via Benzinga
The Analyst Landscape: 6 Takes On PROCEPT BioRobotics
 
Via Benzinga
PROCEPT BioRobotics's Earnings Outlook
 
Via Benzinga
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
Top mid-cap stock performers: MDGL (+51.70%), PRCT (+34.20%), GSAT (+33.98%), WGS (+31.17%), NXT (+25.91%), VFC (+25.82%), OMCL (+23.22%). 
Via Benzinga
Royal Caribbean Sails Onto The IBD 50: Build Your List Of Stocks To Watch With These Top IBD Screens
Royal Caribbean earns its spot on the Big Cap 20 with a best-possible 99 Composite Rating, putting it in the top 1% of all stocks. 
Via Investor's Business Daily
Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential
PROCEPT BioRobotics stock gains as Q3 earnings beat estimates with revenue up 66% YoY, driven by strong system sales and consumable revenue growth. 
Via Benzinga
Topics Earnings
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
 
Via Benzinga
What Analysts Are Saying About PROCEPT BioRobotics Stock
 
Via Benzinga
Navigating 6 Analyst Ratings For PROCEPT BioRobotics
 
Via Benzinga
Unveiling 4 Analyst Insights On PROCEPT BioRobotics
 
Via Benzinga
Procept Biorobotics, A Top 5% Stock, Makes A Bullish Move On Quarterly Beat And Raise
The company sells systems that perform aquablation to treat enlarged prostates. 
Via Investor's Business Daily
Jim Cramer Says This Retailer Yields 3%: 'Which Is Quite Good'
Jim Cramer discusses PROCEPT BioRobotics, Zoetis, Target and Consolidated Edison. " 
Via Benzinga
Lucid, Grifols And Amer Sports Are Among Top 8 Mid Cap Stock Gainers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio?
 
Via Benzinga
Nasdaq Gains 0.5%; TJX Earnings Top Estimates
 
Via Benzinga
Toll Brothers Posts Strong Earnings, Joins Keysight, Coty, TJX And Other Big Stocks Moving Higher On Wednesday
 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.